MedTrace Logo

Stability of Middle Molecule Clearance

NCT01308073 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 15

Last updated 2014-12-19

No results posted yet for this study

Summary

The investigators aim to show, whether all middle molecules are included in the clearance and whether this clearance is stable until 72 hours.

Conditions

  • Continuous Hemodialysis

Interventions

DEVICE

Hemodialysis with EMIC 2 filters

Patients with indication for routine continuous hemodialysis due to acute renal insufficiency

Sponsors & Collaborators

  • Fresenius Medical Care Deutschland GmbH

    collaborator INDUSTRY

  • Klinik für Anästhesiologie

    lead OTHER

Principal Investigators

  • Detlef Kindgen-Milles, Prof. · Klinik für Anästhesiologie Universitätsklinikum Düsseldorf Heinrich-Heine Universität

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-03-31
Primary Completion
2014-11-30
Completion
2014-11-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01308073 on ClinicalTrials.gov